Skip to main content
SpringerLink
Log in

The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases

  • Conference paper
Book cover Immunosurveillance, Immunodeficiencies and Lymphoproliferations

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 159))

Abstract

The Kaposi’s sarcoma-associated herpesvirus (KSHV), also called human herpesvirus 8 (HHV-8), is found invariably in Kaposi’s sarcoma, and compelling evidence suggests that it is an etiologic agent for this disease. KSHV has also been found to be present in a limited subset of lymphoproliferative disorders. Among these are the primary effusion lymphomas, formerly designated body cavity-based lymphomas. This is a rare type of malignant lymphoma which possesses an unusual set of clinical and biologic features, suggesting that it represents a distinct disease entity. This virus is also present in a large proportion of cases of multicentric Castleman’s disease, particularly those associated with HIV infection. In addition, KSHV has been implicated in the pathogenesis of multiple myeloma, but many laboratories including our own have been unable to confirm this association. KSHV carries at least 11 open reading frames (ORFs) that encode homologs to cellular proteins involved in signal transduction, cell cycle regulation, inhibition of apoptosis and/or immune modulation. Therefore, it has the genetic machinery of an oncogenic virus. However, only a small proportion of infected people ever develop Kaposi’s sarcoma or virus-induced lymphoma, and do so only after a long latency period. This observation reflects the multistep nature of oncogenesis, with viral infection representing only one of these steps. Cofactors such as HIV infection and iatrogenic immunosuppression dramatically increase the risk for developing a KSHV-related malignancy in infected individuals. Understanding the oncogenic and immunologic mechanisms involved in the pathobiology of virus-associated lymphomas is important for the development of targeted therapeutic and preventive approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869

    Article  PubMed  CAS  Google Scholar 

  2. Moore PS, Chang Y (1995) Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma lesions from persons with and without HIV infection. N Engl J Med 332:1181–1185

    Article  PubMed  CAS  Google Scholar 

  3. Boshoff C, Whitby D, Hatziionnou T, Fisher C, van der Walt J, Hatzakis A, Weiss R, Schulz T (1995) Kaposi’s sarcoma-associated herpesvirus in HIV-negative Kaposi’s sarcoma. Lancet 345:1043–1044

    Article  PubMed  CAS  Google Scholar 

  4. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P (1995) A role for a new herpes virus (KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1:707–708

    Article  PubMed  CAS  Google Scholar 

  5. de Leilis L, Fabris M, Cassai E, Corallini A, Giraldo G, Feo C, Monini P (1995) Herpesvirus-like DNA sequences in non-AlDS Kaposi’s sarcoma. J Infect Dis 172:1605–1607

    Article  Google Scholar 

  6. Huang YQ, Li H, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE (1995) Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma. Lancet 345:759–761

    Article  PubMed  CAS  Google Scholar 

  7. Tomita Y, Naka N, Aozasa K, Cesarman E, Knowles DK (1995) Absence of Kaposi’s sa reo ma-associated herpesvirus-like DNA sequences (KSHV) in angiosarcomas developing in body-cavity and other sites (letter). Int J Cancer 66:141–142

    Article  Google Scholar 

  8. lin YT, Tsai ST, Yan JJ, Hsiao JH, Lee YY, Su IJ (1996) Detection of Kaposi’s sarcoma-associated herpesvirus-like DNA sequence in vascular lesions: a reliable diagnostic marker for Kaposi’s sarcoma. Am J Clin Pathol 105:360–363

    Google Scholar 

  9. Kemeny L, Kiss M, Gyulai R, Dobozy A, Adam E, Nagy F (1996) Herpesvirus-like nucleic acid sequences in patients with Eastern European sporadic Kaposi’s sarcoma (letter). J Invest Dermatol 106:381

    Article  PubMed  CAS  Google Scholar 

  10. Dictor M, Rambech E, Way D, Witte M, Bendsöe N (1996) Human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) DNA in Kaposi’s sarcoma lesions, AIDS Kaposi’s sarcoma cell lines, endothelial Kaposi’s sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 148:2009–2016

    PubMed  CAS  Google Scholar 

  11. Cesarman E, Chang Y, Moore PS, Said JW Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 332:1186–1191

    Article  PubMed  CAS  Google Scholar 

  12. Karcher DS, Alkan S (1995) Herpes-like DNA sequences, AIDS-related tumors, and Castleman’s disease (letter). N Engl J Med 333:797–798

    Article  PubMed  CAS  Google Scholar 

  13. Pastore C, Gloghini A, Voipe G, Nomdedeu J, Leonardo E, Mazza U, Saglio G, Carbone A, Gaidano G (1995) Distribution of Kaposi’s sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br J Haematol 91:918–920

    Article  PubMed  CAS  Google Scholar 

  14. Carbone A, Tirelli U, Gloghini A, Pastore C, Vaccher E, Gaidano G (1996) Herpesvirus-like DNA sequences selectively cluster with body cavity-based lymphomas throughout the spectrum of AIDS-related lymphomatous effusions (letter). Eur J Cancer 32A:555–556

    Article  PubMed  CAS  Google Scholar 

  15. Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeid M (1996) Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 10:1358–1362

    PubMed  CAS  Google Scholar 

  16. Gessain A, Brière J, Angelin-Duclos C, Valensi F, Merle Béral H, Davi F, Nicola M-A, Sudaka A, Fouchard N, Gabarre J, Troussard X, Dulmet E, Audouin J, Diebold J, de Thé G (1997) Human herpes virus 8 (Kaposi’s sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia 11:266–272

    Article  PubMed  CAS  Google Scholar 

  17. Nador RG, Cesarman E, Knowles DM, Said IW (1995) Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient (letter). N Engl J Med 333:943

    Article  PubMed  CAS  Google Scholar 

  18. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpesvirus. Blood 88:645–656

    PubMed  CAS  Google Scholar 

  19. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP (1996) Primary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma-herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 88:3124–3128

    PubMed  CAS  Google Scholar 

  20. Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G (1996) Kaposi’s sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 94:533–543

    Article  PubMed  CAS  Google Scholar 

  21. Karcher DS, Alkan S (1997) Human herpesvirus-6 associated body cavity based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol 28:801–808

    Article  PubMed  CAS  Google Scholar 

  22. Gaidano G, Pastore C, Gloghini A, Volpe G, Capello D, Polito P, Vaccher E, Tirelli U, Saglio G, Carbone A (1997) Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma 24:257–266

    PubMed  CAS  Google Scholar 

  23. Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153:1609–1614

    Article  PubMed  CAS  Google Scholar 

  24. Fais R Gaidano G, Capello D, Gloghini A, Ghiotto R Roncella S, Carbone A, Chiorazzi N, Ferrarini M (1999) Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia 13:1093–1099

    Article  PubMed  CAS  Google Scholar 

  25. Gaidano G, Gloghini A, Gattei V, Rossi MR Cilia AM, Godeas C, Degan M, Perin T, Canzonieri V, Aldinucci D, Saglio G, Carbone A, Pinto A (1997) Association of Kaposi’s sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-l antigen. Blood 90:4894–4900

    PubMed  CAS  Google Scholar 

  26. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus human herpesvirus-8. Blood 90:1186–1191

    PubMed  CAS  Google Scholar 

  27. Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Lowbeer M, Lennette ET, Klein G (1998) Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV-and human herpesvirus type 8-carrying body cavity lymphoma line. Gen Virol 79:1445–1452

    CAS  Google Scholar 

  28. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, Antinori A, Tirelli U, Falini B, Dalla-Favera R (1998) Differential expression of BCL-6, CD138/syndecan-l, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas. Blood 91:747–755

    PubMed  CAS  Google Scholar 

  29. Drexler HG, Uphoff CC, Gaidano G, Carbone A (1998) Lymphoma cell lines: in vitro models for the study of HHV-8-1-primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12:1507–1517

    Article  PubMed  CAS  Google Scholar 

  30. Russo JJ, Bohenzky RA, Chien M-C, Chen J, Yan M, Maddalena D, Parry JR Peruzzi D, Edelman IS, Chang Y, Moore PS (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93:14862–14867

    Article  PubMed  CAS  Google Scholar 

  31. Gao SJ, Boschoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS (1997) KSHV ORE K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979–1985

    Article  PubMed  CAS  Google Scholar 

  32. Zimring JC, Goodbourn S, Offermann MK (1998) Human herpesvirus 8 encodes an interferon regulatory factor (IRE) homolog that represses IRF-1-mediated transcription. J Virol 72:701–707

    PubMed  CAS  Google Scholar 

  33. Li M, Lee H, Guo J, Neipel E, Fleckenstein B, Ozato K, Jung JU (1998) Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 1998:5433–5440

    Google Scholar 

  34. Arvanitakis L, Geras-Raaka E, Gershengorn MC, Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G protein-coupled receptor linked to cell proliferation. Nature 385:347–350

    Article  PubMed  CAS  Google Scholar 

  35. Bais C, Santomasso B, Coso O, Arvanitakis L, Geras Raaka E, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri E (1998) G-protein-cou pled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86–89

    Article  PubMed  CAS  Google Scholar 

  36. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, Lackner A, Desrosiers RC, Jung JU (1998) Deregulation of cell growth by the Kl gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 4:435–440

    Article  PubMed  CAS  Google Scholar 

  37. Muralidhar S, Pumfrery A, Hassani M, Sadaie MR, Azumi N, Brady JN, Medveszky R Rosenthal LJ (1998) Identification of Kaposin (ORE K12) as a human herpesvirus 8 (Kaposi’s sarcoma associated herpesvirus) oncogene. J AIDS Hum Retrovirol 17:A27

    Google Scholar 

  38. Radkov SA, Kellam P, Boshoff C (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene h-ras transforms primary rat cells. Nat Med 6:1121–1127

    Article  PubMed  CAS  Google Scholar 

  39. Moore PS, Boschoff C, Weiss RA, Chang Y (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–1744

    Article  PubMed  CAS  Google Scholar 

  40. Thome M, Schneider P, Hofmann K, Fickenscher H, MeinI E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517–521

    Article  PubMed  CAS  Google Scholar 

  41. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT (1997) Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71:715–719

    PubMed  CAS  Google Scholar 

  42. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS (1998) Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma ceU line (BC-1). J Virol 72:1005–1012

    PubMed  CAS  Google Scholar 

  43. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA (1997) Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290–294

    Article  PubMed  CAS  Google Scholar 

  44. Flore O, Rafii S, Ely S, O’Leary JJ, Hyjek EM, Cesarman E (1998) Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 394:588–592

    Article  PubMed  CAS  Google Scholar 

  45. Rettig MB, Ma HJ, Vescio RA, Põld M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR (1997) Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851–1854

    Article  PubMed  CAS  Google Scholar 

  46. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay M-F, Clauvel J-P, Raphael M, Degos L, Sigaux F (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86:1275–1280

    Google Scholar 

  47. Gessain A, Sudaka A, Brière J, Fouchard N, Nicola M-A, Rio B, Arborio M, Troussard X, Ausouin J, Diebold J, de Thé G (1995) Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman’s disease: Is there any relevant association in non-human immunodeficiency virus-infected patients? (letter). Blood 87:414–416

    Google Scholar 

  48. Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM (1996) Kaposi’s sarcoma-associated herpesvirus sequences in non-HIV-associated benign lymphoproliferative lesions. Lab Invest 74:109A

    Google Scholar 

  49. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, Cazals-Hatem D, Autran B, Clauvel J-P Raphael M (1996) Muhicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 10:61–67

    Article  PubMed  CAS  Google Scholar 

  50. Frizzera G (1992) Atypical lymphoproliferative disorders. In: Knowles DM, ed. Neoplastic hematopathology. Baltimore: Williams and Wilkins, pp 459–496

    Google Scholar 

  51. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman’s disease. Am J Pathol 151:1517–1522

    PubMed  CAS  Google Scholar 

  52. Dupin N, Diss TL, Kellam R Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406–12

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Center for Lymphoma and Myeloma, The Weill Medical College of Cornell University New York Presbyterian, Hospital, 1300 York Avenue, New York, NY, 10021, USA

    Ethel Cesarman

Authors
  1. Ethel Cesarman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Charité-Campus Virchow Medizinische Klinik mit Schwerpunkt Hämatologie/Onkologie, Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany

    Stephan H. Oertel  & Hanno Riess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cesarman, E. (2002). The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases. In: Oertel, S.H., Riess, H. (eds) Immunosurveillance, Immunodeficiencies and Lymphoproliferations. Recent Results in Cancer Research, vol 159. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56352-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56352-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62676-0

  • Online ISBN: 978-3-642-56352-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation